Replies to post #101080 on Biotech Values

[DewDiligence]

Despite the IBD article, this drug seems to be a complex type of sugar not a protein.

Correct—Lovenox is not a protein. The IBD author was simply uninformed on this score. Regards, Dew

[mauser96]

Thanks to those who sent me private messages re MNTA stock price. I'm not yet a Premium Member so can't reply privately.
Thanks also to those who post here. This is really an exceptional board, one of the best I've ever read.

I did decide to dip my toes back in the water in the low 17's. With anything involving the FDA I need at least a potential double to make it worth the risk.

I suspect that generics will rapidly capture the majority of this market.
The behavior and pricing policies of Sanofi might be predicted based on their pricing of Ambien. This drug for insomnia was nearly unique with little competition. Then after many years they got competitors, and a generic Ambien. The pricing (at Drugstore.com) of branded Ambien 10mg is $594.788 per 100, for 100 of the generic it's $51.08. So I don't think that Sanofi is going to fight a price war. A smaller market share wih huge profits per use is better for them. They need to devote few resources to it, probably most of the machinery is either shared or long since depreciated.